Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery
NCT07225140Phase 3Not yet recruiting
- Sponsor
- AFT Pharmaceuticals
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetaminophen + ibuprofen in postoperative pain, sponsored by AFT Pharmaceuticals. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07225140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07225140.